Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Palazu Mare – page 4

118 clinical trials in Palazu Mare, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Palazu Mare at a glance
118
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

118 trials in Palazu Mare

Open in trial search

Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Daiichi Sankyo Inc.

Psychotic disorder+1

Recruiting

Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Vidofludimus Calcium
  • Sponsor:Immunic AG

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Psychotic disorder+1

Recruiting

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Karuna Therapeutics Inc.

Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Grifols Therapeutics LLC

Cardiovascular disorder+3

Not yet recruiting

Study of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Non-small cell lung cancer

Not yet recruiting

Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Immunitybio Inc.

Colitis ulcerative

Not yet recruiting

Evaluation of the Efficacy and Safety of Ponesimod in Patients with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ponesimod
  • Sponsor:Vanda Pharmaceuticals Inc.

Type 2 diabetes mellitus

Not yet recruiting

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Albiglutide
  • Sponsor:Eli Lilly & Co.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Palazu Mare

What the registry says about research in the country

01 Respiratory Diseases - Asthma Studies

Innovative research focusing on moderate to severe asthma treatments, including evaluation of new inhalation devices and formulations. Studies are examining advanced therapeutic combinations to improve patient outcomes in eosinophilic asthma.

  • Bronchodilator Safety Assessment
  • Novel Propellant Evaluation
  • Pulmonary Function Studies

These trials aim to enhance treatment options for patients requiring Step 4 and Step 5 interventions according to current guidelines.

02 COPD Management Research

Comprehensive studies evaluating chronic obstructive pulmonary disease treatments through both fixed-dose combinations and innovative biological therapies.

  • Triple Combination Therapies
  • Lung Function Improvement
  • Exacerbation Prevention

Research focuses on comparing various therapeutic approaches to improve pre-dose lung function and reduce acute exacerbations in COPD patients.

03 Advanced Respiratory Therapeutics

Cutting-edge investigations into novel respiratory medications, including targeted biological treatments and innovative delivery systems for both asthma and COPD management.

  • Long-term Safety Evaluation
  • Comparative Efficacy Studies
  • Patient Response Assessment

These clinical trials aim to expand the therapeutic arsenal available for treating chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.